Blog

Elevate your drug development programs – The START Center for Cancer Research

Photo taken from The START Center for Cancer Research/LinkedIn

Jun 28, 2024, 15:18

Elevate your drug development programs – The START Center for Cancer Research

The START Center for Cancer Research recently shared a post on LinkedIn:

“Are you attending Tumor Models Boston this year? We hope to see you there!

Visit our booth and attend Dr. Michael Wick, Ph.D.’s presentation on July 23rd at 10 AM: “Navigating the Preclinical Oncology Landscape: The Search for Clinically Relevant PDX Models.”

Discover how XenoSTART can elevate your drug development programs with over 2,500 high-quality PDX models, representing 27+ tumor types – the broadest set of indications in the industry. Join us for a deep dive at the conference.

Schedule a meeting today.”

Source: The START Center for Cancer Research/LinkedIn
.

cancer Cancer research clinical trials drug development Michael Wick OncoDaily Oncology Oncology Conference PDX models preclinical oncology START Center for Cancer Research Tumor Models Boston XenoSTART

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage